ProfileGDS4132 / 206810_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 32% 34% 28% 31% 30% 40% 35% 23% 32% 47% 39% 33% 26% 25% 41% 42% 28% 36% 35% 44% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10179.541632
GSM201543Muscle PCOS pioglitazone 12177.231334
GSM201544Muscle PCOS pioglitazone 16171.125528
GSM201545Muscle PCOS pioglitazone 20183.64631
GSM201829Muscle PCOS pioglitazone 23177.358130
GSM201830Muscle PCOS pioglitazon 251107.32140
GSM201831Muscle PCOS pioglitazone 27186.717935
GSM201832Muscle PCOS pioglitazone 3153.717623
GSM201833Muscle PCOS pioglitazone 4174.68732
GSM201834Muscle PCOS pioglitazone 81122.19947
GSM201835Muscle PCOS after pioglitazone 10285.972239
GSM201836Muscle PCOS after pioglitazone 12270.957133
GSM201837Muscle PCOS after pioglitazone 16250.526626
GSM201838Muscle PCOS after pioglitazone 20252.485925
GSM201839Muscle PCOS after pioglitazone 23298.033241
GSM201840Muscle PCOS after pioglitazone 252104.02642
GSM201841Muscle PCOS after pioglitazone 27253.173628
GSM201842Muscle PCOS after pioglitazone 3275.207636
GSM201843Muscle PCOS after pioglitazone 4285.639135
GSM201844Muscle PCOS after pioglitazone 82110.52544